HomeBAFNAPH • NSE
add
Bafna Pharmaceuticals Ltd
Previous close
₹78.24
Day range
₹77.00 - ₹80.65
Year range
₹69.00 - ₹96.00
Market cap
1.94B INR
Avg Volume
2.97K
P/E ratio
45.45
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 390.60M | -5.65% |
Operating expense | 95.80M | -11.73% |
Net income | 13.11M | -9.92% |
Net profit margin | 3.36 | -4.55% |
Earnings per share | — | — |
EBITDA | 41.19M | 28.24% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.33M | 145.90% |
Total assets | 1.53B | 3.65% |
Total liabilities | 682.73M | 2.14% |
Total equity | 848.06M | — |
Shares outstanding | 23.84M | — |
Price to book | 2.20 | — |
Return on assets | — | — |
Return on capital | 6.75% | — |
Cash Flow
Net change in cash
| (INR) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 13.11M | -9.92% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1981
Website
Employees
363
